Zhejiang Chemsyn Pharm920656.BJValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 19, 2026, Zhejiang Chemsyn Pharm (920656.BJ) trades at a P/E of 16.30x, P/B of 1.98x, P/S of 4.97x, and a dividend yield of 2.85%.
Longitudinal percentile comparison: P/E sits at the 15th percentile over the trailing 10Y window (vs. 15th percentile over 3Y); P/B sits at the 30th percentile over the trailing 10Y window (vs. 30th percentile over 3Y); P/S sits at the 2nd percentile over the trailing 10Y window (vs. 2nd percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 13th percentile within its industry and the 17th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 2.85%, ranking at the 70th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 15.1 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Zhejiang Chemsyn Pharm operates in the — sector. Data refreshes weekly and is for reference only, not investment advice.
Want the full picture on whether Zhejiang Chemsyn Pharm (920656.BJ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 16.30 | ||||||
| P/B (MRQ) | 1.98 | ||||||
| P/S (TTM) | 4.97 | ||||||
| Dividend Yield | 2.85% | ||||||
| Buyback + Div Yield | 2.85% |